Brind.

Blom was appointed to Avacta Therapeutics' Board of Directors, and Paul Fry stepped down from the board on September 14, 2026.

1 report, 1 independent Updated Sep 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Blom was appointed to Avacta Therapeutics' Board of Directors, and Paul Fry stepped down from the board on September 14, 2026.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Blom

    Norwegian company

    Nothing else this week.

  • Paul Fry

    American academic

    Nothing else this week.

Coverage

Newest first; wire copies grouped